Literature DB >> 26305142

[Erdheim-Chester disease and Rosai-Dorfman disease: Pathological, radiological and clinical features of adult non-Langerhans cell histiocytosis].

H Bösmüller1, D Nann, M Horger, F Fend.   

Abstract

Non-Langerhans cell histiocytoses (N-LCH) of adulthood are rare disorders with heterogeneous pathogenesis, morphology and clinical presentation. In this review two disorders are presented, which predominantly develop in extracutaneous sites in adults. Erdheim-Chester disease is a rare nonhereditary clonal disorder of lipid storing histiocytes most commonly presenting as osseous involvement of the long bones. Other organ manifestations include the central nervous system (CNS), the cardiovascular system, the retroperitoneum and kidneys and less commonly the skin and the lungs. Immunohistochemical staining reveals positivity for the macrophage markers CD163, CD68 and lysozyme but CD1a and langerin are negative, in contrast to Langerhans cell histiocytosis. Rosai-Dorfman disease is considered to be a reactive histiocytic proliferation occurring mainly in lymph nodes. Prominent sinuses filled with commonly multinucleated, S100-positive histiocytes with emperipolesis are a characteristic feature and develops particularly as extensive lymphadenopathy with massive sinus histiocytosis but can also occur extranodally. Painless bilateral cervical lymph node enlargement is the most common clinical presentation. This review summarizes the clinical, radiological and histopathological findings and discusses the recent molecular advances in these rare disorders.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26305142     DOI: 10.1007/s00292-015-0057-4

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  39 in total

1.  Spinal dural involvement in Erdheim-Chester disease: MRI findings.

Authors:  Sait Albayram; Osman Kizilkilic; Zuzan Zulfikar; Civan Islak; Naci Kocer
Journal:  Neuroradiology       Date:  2002-10-03       Impact factor: 2.804

2.  Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease.

Authors:  Jean-François Emile; Eli L Diamond; Zofia Hélias-Rodzewicz; Fleur Cohen-Aubart; Frédéric Charlotte; David M Hyman; Eunhee Kim; Raajit Rampal; Minal Patel; Chezi Ganzel; Shlomzion Aumann; Gladwys Faucher; Catherine Le Gall; Karen Leroy; Magali Colombat; Jean-Emmanuel Kahn; Salim Trad; Philippe Nizard; Jean Donadieu; Valérie Taly; Zahir Amoura; Omar Abdel-Wahab; Julien Haroche
Journal:  Blood       Date:  2014-08-22       Impact factor: 22.113

3.  Clonal cytogenetic abnormalities in Erdheim-Chester disease.

Authors:  Eneida F Vencio; Robert B Jenkins; Jamie L Schiller; Tuong Vy T Huynh; Doris D Wenger; Carrie Y Inwards; Andre M Oliveira
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

4.  Imaging of thoracoabdominal involvement in Erdheim-Chester disease.

Authors:  Elisabeth Dion; Claire Graef; Julien Haroche; Raphaële Renard-Penna; Philippe Cluzel; Bertrand Wechsler; Jean-Charles Piette; Philippe A Grenier
Journal:  AJR Am J Roentgenol       Date:  2004-11       Impact factor: 3.959

Review 5.  Erdheim-Chester disease involving the breast--a rare but important differential diagnosis.

Authors:  Shuangping Guo; Qingguo Yan; Joseph Rohr; Yingmei Wang; Linni Fan; Zhe Wang
Journal:  Hum Pathol       Date:  2014-10-18       Impact factor: 3.466

Review 6.  More than just Langerhans cell histiocytosis: a radiologic review of histiocytic disorders.

Authors:  Jatin Zaveri; Quan La; Gail Yarmish; Jeremy Neuman
Journal:  Radiographics       Date:  2014 Nov-Dec       Impact factor: 5.333

Review 7.  [Immunoglobulin G4 (IgG4)-related disease. A review of head and neck manifestations].

Authors:  A Agaimy; S Ihrler
Journal:  Pathologe       Date:  2014-03       Impact factor: 1.011

8.  Erdheim-Chester disease with epiphyseal and systemic disease.

Authors:  N A Athanasou; C Barbatis
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

9.  Chester-Erdheim disease: a neoplastic disorder.

Authors:  J Chetritt; V Paradis; D Dargere; H Adle-Biassette; C A Maurage; J M Mussini; A Vital; J Wechsler; P Bedossa
Journal:  Hum Pathol       Date:  1999-09       Impact factor: 3.466

10.  Clonal status and clinicopathological feature of Erdheim-Chester disease.

Authors:  Li Gong; Xian-Li He; Yan-Hong Li; Kai-Xi Ren; Li Zhang; Xiao-Yan Liu; Xiu-Juan Han; Li Yao; Shao-Jun Zhu; Miao Lan; Wei Zhang
Journal:  Pathol Res Pract       Date:  2009-04-01       Impact factor: 3.250

View more
  3 in total

Review 1.  [Updates to the WHO classification of bone tumours].

Authors:  G Jundt
Journal:  Pathologe       Date:  2018-03       Impact factor: 1.011

2.  Inflammatory response under zinc deficiency is exacerbated by dysfunction of the T helper type 2 lymphocyte-M2 macrophage pathway.

Authors:  Takamasa Kido; Kenji Ishiwata; Machi Suka; Hiroyuki Yanagisawa
Journal:  Immunology       Date:  2019-01-21       Impact factor: 7.397

3.  Rare diseases of bone: Erdheim-Chester and Rosai-Dorfman non-Langerhans cell histiocytoses.

Authors:  Andreas F Mavrogenis; Vasilios G Igoumenou; Thekla Antoniadou; Panayiotis D Megaloikonomos; George Agrogiannis; Periklis Foukas; Sotirios G Papageorgiou
Journal:  EFORT Open Rev       Date:  2018-06-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.